×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ATHA – athira pharma, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ATHA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/7
04:18 pm
atha
Athira Pharma Reports Third Quarter 2024 Financial Results and Pipeline and Business Updates [Yahoo! Finance]
High
Report
Athira Pharma Reports Third Quarter 2024 Financial Results and Pipeline and Business Updates [Yahoo! Finance]
11/7
04:05 pm
atha
Athira Pharma Reports Third Quarter 2024 Financial Results and Pipeline and Business Updates
Medium
Report
Athira Pharma Reports Third Quarter 2024 Financial Results and Pipeline and Business Updates
10/22
07:00 am
atha
Athira Pharma to Present Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton at the Clinical Trials on Alzheimer’s Disease (CTAD) 2024 Meeting
High
Report
Athira Pharma to Present Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton at the Clinical Trials on Alzheimer’s Disease (CTAD) 2024 Meeting
9/19
07:58 am
atha
Athira Pharma, Inc. (NASDAQ: ATHA) was downgraded by analysts at Mizuho from an "outperform" rating to a "neutral" rating. They now have a $0.50 price target on the stock, down previously from $5.00.
Low
Report
Athira Pharma, Inc. (NASDAQ: ATHA) was downgraded by analysts at Mizuho from an "outperform" rating to a "neutral" rating. They now have a $0.50 price target on the stock, down previously from $5.00.
9/17
09:00 am
atha
Athira Pharma to Focus on Advancement of ATH-1105 for the Treatment of Neurodegenerative Diseases
Medium
Report
Athira Pharma to Focus on Advancement of ATH-1105 for the Treatment of Neurodegenerative Diseases
9/4
08:54 am
atha
Athira Pharma's Alzheimer's Candidate Fails To Improve Cognition And Function In Patients With Mild/Moderate Disease, Stock Sinks [Yahoo! Finance]
High
Report
Athira Pharma's Alzheimer's Candidate Fails To Improve Cognition And Function In Patients With Mild/Moderate Disease, Stock Sinks [Yahoo! Finance]
9/4
08:37 am
atha
Athira Pharma, Inc. (NASDAQ: ATHA) was downgraded by analysts at Rodman & Renshaw from a "buy" rating to a "neutral" rating.
High
Report
Athira Pharma, Inc. (NASDAQ: ATHA) was downgraded by analysts at Rodman & Renshaw from a "buy" rating to a "neutral" rating.
9/4
07:38 am
atha
Athira Pharma, Inc. (NASDAQ: ATHA) was downgraded by analysts at BTIG Research from a "buy" rating to a "neutral" rating.
High
Report
Athira Pharma, Inc. (NASDAQ: ATHA) was downgraded by analysts at BTIG Research from a "buy" rating to a "neutral" rating.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
04:18 pm
atha
Form SC 13G/A Athira Pharma, Inc. Filed by: BAKER BROS. ADVISORS LP
Medium
Report
Form SC 13G/A Athira Pharma, Inc. Filed by: BAKER BROS. ADVISORS LP
11/7
04:21 pm
atha
Form 10-Q Athira Pharma, Inc. For: Sep 30
Medium
Report
Form 10-Q Athira Pharma, Inc. For: Sep 30
11/7
04:12 pm
atha
Form 8-K Athira Pharma, Inc. For: Nov 07
Medium
Report
Form 8-K Athira Pharma, Inc. For: Nov 07
11/7
01:15 pm
atha
Form SC 13G Athira Pharma, Inc. Filed by: BML Investment Partners, L.P.
Low
Report
Form SC 13G Athira Pharma, Inc. Filed by: BML Investment Partners, L.P.
10/31
04:17 pm
atha
Form SC 13D/A Athira Pharma, Inc. Filed by: PERCEPTIVE ADVISORS LLC
High
Report
Form SC 13D/A Athira Pharma, Inc. Filed by: PERCEPTIVE ADVISORS LLC
10/29
06:03 am
atha
Form EFFECT Athira Pharma, Inc.
Low
Report
Form EFFECT Athira Pharma, Inc.
10/18
04:03 pm
atha
Form 8-K Athira Pharma, Inc. For: Oct 16
Medium
Report
Form 8-K Athira Pharma, Inc. For: Oct 16
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: